Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Cervical Cancer

  Free Subscription


13.05.2019

2 Acta Cytol
2 Arch Gynecol Obstet
1 Asia Pac J Clin Oncol
1 Asian Pac J Cancer Prev
1 Biochem Biophys Res Commun
1 BMB Rep
3 BMC Cancer
2 BMC Public Health
1 Cureus
5 Diagn Cytopathol
1 Fundam Clin Pharmacol
1 Int J Environ Res Public Health
1 Int J Gynaecol Obstet
2 Int J Mol Sci
2 Int J Oncol
1 J Cell Biochem
1 J Digit Imaging
2 J Glob Oncol
2 J Gynecol Oncol
1 J Infect Dis
1 J Minim Invasive Gynecol
1 J Vasc Interv Radiol
1 LGBT Health
1 Med Sci Monit
1 Mol Immunol
1 Oncoimmunology
1 PeerJ
3 PLoS One
1 Rev Assoc Med Bras (1992)
1 Saudi Med J
1 South Asian J Cancer
1 Taiwan J Obstet Gynecol
1 Wiad Lek
1 Zhongguo Yi Xue Ke Xue Yuan Xue Bao


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Cytol

  1. SRIVASTAVA AN, Misra JS, Singh U, Khan M, et al
    AgNOR Pleomorphic Count as a Tumor Marker in Cervical Carcinogenesis and Feasibility of Its Introduction in Cervical Cancer Screening Programs to Discriminate High-Risk Cases of Squamous Intraepithelial Lesions of the Cervix.
    Acta Cytol. 2019 May 8:1-8. doi: 10.1159/000498978.
    PubMed     Text format     Abstract available

  2. PAASO A, Jaakola A, Syrjanen S, Louvanto K, et al
    From HPV Infection to Lesion Progression: The Role of HLA Alleles and Host Immunity.
    Acta Cytol. 2019;63:148-158.
    PubMed     Text format     Abstract available


    Arch Gynecol Obstet

  3. PRODROMIDOU A, Iavazzo C, Fotiou A, Psomiadou V, et al
    Short- and long term outcomes after abdominal radical trachelectomy versus radical hysterectomy for early stage cervical cancer: a systematic review of the literature and meta-analysis.
    Arch Gynecol Obstet. 2019 May 6. pii: 10.1007/s00404-019-05176.
    PubMed     Text format     Abstract available

  4. PAPATLA K, Houck KL, Hernandez E, Chu C, et al
    Second primary uterine malignancies after radiation therapy for cervical cancer.
    Arch Gynecol Obstet. 2019 May 8. pii: 10.1007/s00404-019-05187.
    PubMed     Text format     Abstract available


    Asia Pac J Clin Oncol

  5. HOU X, Wang W, Zhang F, Hu K, et al
    Stereotactic body radiation therapy for oligometastatic pulmonary tumors from cervical cancer.
    Asia Pac J Clin Oncol. 2019 May 8. doi: 10.1111/ajco.13159.
    PubMed     Text format     Abstract available


    Asian Pac J Cancer Prev

  6. SUL 'AIN MD, Zakaria F, Johan MF
    Anti-Proliferative Effects of Methanol and Water Extracts of Pyrrosia piloselloides on the Hela Human Cervical Carcinoma Cell Line
    Asian Pac J Cancer Prev. 2019;20:185-192.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  7. SU J, Zhang F, Li X, Liu Z, et al
    Osthole promotes the suppressive effects of cisplatin on NRF2 expression to prevent drug-resistant cervical cancer progression.
    Biochem Biophys Res Commun. 2019 May 2. pii: S0006-291X(19)30643.
    PubMed     Text format     Abstract available


    BMB Rep

  8. KIM DH, Kim HM, Huong PTT, Han HJ, et al
    Enhanced anticancer effects of a methylation inhibitor by inhibiting a novel DNMT1 target, CEP 131, in cervical cancer.
    BMB Rep. 2019 May 9. pii: 4547.
    PubMed     Text format     Abstract available


    BMC Cancer

  9. YE J, Cheng XD, Cheng B, Cheng YF, et al
    MiRNA detection in cervical exfoliated cells for missed high-grade lesions in women with LSIL/CIN1 diagnosis after colposcopy-guided biopsy.
    BMC Cancer. 2019;19:112.
    PubMed     Text format     Abstract available

  10. EGLI-GANY D, Spaar Zographos A, Diebold J, Masserey Spicher V, et al
    Human papillomavirus genotype distribution and socio-behavioural characteristics in women with cervical pre-cancer and cancer at the start of a human papillomavirus vaccination programme: the CIN3+ plus study.
    BMC Cancer. 2019;19:111.
    PubMed     Text format     Abstract available

  11. PARK S, Kim J, Eom K, Oh S, et al
    microRNA-944 overexpression is a biomarker for poor prognosis of advanced cervical cancer.
    BMC Cancer. 2019;19:419.
    PubMed     Text format     Abstract available


    BMC Public Health

  12. IFEDIORA CO
    Re-thinking breast and cervical cancer preventive campaigns in developing countries: the case for interventions at high schools.
    BMC Public Health. 2019;19:503.
    PubMed     Text format     Abstract available

  13. NYAMBE A, Kampen JK, Baboo SK, Van Hal G, et al
    Knowledge, attitudes and practices of cervical cancer prevention among Zambian women and men.
    BMC Public Health. 2019;19:508.
    PubMed     Text format     Abstract available


    Cureus

  14. RODRIGUEZ J, Castro JC, Beltran M, Forero O, et al
    Simultaneous Metastasis from Cervical Cancer to the Kidney and Paraspinal Muscle: A Case Report.
    Cureus. 2019;11:e4148.
    PubMed     Text format     Abstract available


    Diagn Cytopathol

  15. ERDEM BE, Cigdem V, Sener G, Bahar M, et al
    Smear cytological features of large cell neuroendocrine carcinoma of the uterine cervix in pregnancy: A case report and review of the literature.
    Diagn Cytopathol. 2018 Nov 21. doi: 10.1002/dc.24106.
    PubMed     Text format     Abstract available

  16. HARBHAJANKA A, Chahar S, Michael CW
    The pathological outcome of ThinPrep Pap tests diagnosed as glandular cell abnormalities alone versus combined glandular and squamous abnormalities.
    Diagn Cytopathol. 2019;47:88-93.
    PubMed     Text format     Abstract available

  17. KARACA I, Ozturk M, Comba C, Demirayak G, et al
    Does the 'equal management of equal risks' model cause overtreatment in patients with positive cervical cytology results for ASCUS/non-HPV16/18 oncogenic types?
    Diagn Cytopathol. 2019;47:105-109.
    PubMed     Text format     Abstract available

  18. SENELDIR H, Kir G
    Prevalence of high-risk human papilloma virus in liquid-based cervical samples from Turkish women with normal and abnormal cytology.
    Diagn Cytopathol. 2019;47:100-104.
    PubMed     Text format     Abstract available

  19. BARRIGON A, Ziadi S, Jacot-Guillarmod M, Da Silva S, et al
    Nabothian cyst content: A potential pitfall for the diagnosis of invasive cancer on Pap test cytology.
    Diagn Cytopathol. 2019;47:127-129.
    PubMed     Text format     Abstract available


    Fundam Clin Pharmacol

  20. PAN Q, Xu J, Ma L
    Simvastatin enhances chemotherapy in cervical cancer via inhibition of multiple prenylation-dependent GTPases-regulated pathways.
    Fundam Clin Pharmacol. 2019 May 6. doi: 10.1111/fcp.12479.
    PubMed     Text format     Abstract available


    Int J Environ Res Public Health

  21. PIKALA M, Burzynska M, Maniecka-Bryla I
    Years of Life Lost Due to Cervical Cancer in Poland in 2000 to 2015.
    Int J Environ Res Public Health. 2019;16.
    PubMed     Text format     Abstract available


    Int J Gynaecol Obstet

  22. ADSUL P, Srinivas V, Gowda S, Nayaka S, et al
    A community-based, cross-sectional study of hrHPV DNA self-sampling-based cervical cancer screening in rural Karnataka, India.
    Int J Gynaecol Obstet. 2019 May 10. doi: 10.1002/ijgo.12859.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  23. BOSSLER F, Hoppe-Seyler K, Hoppe-Seyler F
    PI3K/AKT/mTOR Signaling Regulates the Virus/Host Cell Crosstalk in HPV-Positive Cervical Cancer Cells.
    Int J Mol Sci. 2019;20.
    PubMed     Text format     Abstract available

  24. AKHTAR A, Ghali L, Wang SX, Bell C, et al
    Optimisation of Folate-Mediated Liposomal Encapsulated Arsenic Trioxide for Treating HPV-Positive Cervical Cancer Cells In Vitro.
    Int J Mol Sci. 2019;20.
    PubMed     Text format     Abstract available


    Int J Oncol

  25. ZHA H, Li X, Sun H, Duan L, et al
    S100A9 promotes the proliferation and migration of cervical cancer cells by inducing epithelialmesenchymal transition and activating the Wnt/betacatenin pathway.
    Int J Oncol. 2019 May 2. doi: 10.3892/ijo.2019.4793.
    PubMed     Text format     Abstract available

  26. ZHOU Y, Wang W, Wei R, Jiang G, et al
    Serum bradykinin levels as a diagnostic marker in cervical cancer with a potential mechanism to promote VEGF expression via BDKRB2.
    Int J Oncol. 2019 May 2. doi: 10.3892/ijo.2019.4792.
    PubMed     Text format     Abstract available


    J Cell Biochem

  27. NASEEM A, Bhat ZI, Kalaiarasan P, Kumar B, et al
    Assessment of epigenetic alterations and in silico analysis of mutation affecting PTEN expression among Indian cervical cancer patients.
    J Cell Biochem. 2019 May 9. doi: 10.1002/jcb.28856.
    PubMed     Text format     Abstract available


    J Digit Imaging

  28. YI D, Kong L, Zhao Y
    Contrast-Enhancing Snapshot Narrow-Band Imaging Method for Real-Time Computer-Aided Cervical Cancer Screening.
    J Digit Imaging. 2019 May 8. pii: 10.1007/s10278-019-00215.
    PubMed     Text format     Abstract available


    J Glob Oncol

  29. ZAMORANO AS, Barnoya J, Gharzouzi E, Chrisman Robbins C, et al
    Treatment Compliance as a Major Barrier to Optimal Cervical Cancer Treatment in Guatemala.
    J Glob Oncol. 2019;5:1-5.
    PubMed     Text format     Abstract available

  30. BING EG, Parham GP, Cuevas A, Fisher B, et al
    Using Low-Cost Virtual Reality Simulation to Build Surgical Capacity for Cervical Cancer Treatment.
    J Glob Oncol. 2019;5:1-7.
    PubMed     Text format     Abstract available


    J Gynecol Oncol

  31. VALE DB, Cavalcante LA, Andrade LALA, Teixeira JC, et al
    Stage and histology of cervical cancer in women under 25 years old.
    J Gynecol Oncol. 2019 Feb 26. pii: 30.e55. doi: 10.3802/jgo.2019.
    PubMed     Text format     Abstract available

  32. TANGJITGAMOL S, Tharavichitkul E, Tovanabutra C, Rongsriyam K, et al
    A randomized controlled trial comparing concurrent chemoradiation versus concurrent chemoradiation followed by adjuvant chemotherapy in locally advanced cervical cancer patients: ACTLACC trial.
    J Gynecol Oncol. 2019 Apr 10. pii: 30.e82. doi: 10.3802/jgo.2019.
    PubMed     Text format     Abstract available


    J Infect Dis

  33. ZHAO X, Zhao S, Hu S, Zhao K, et al
    Role of Human Papillomavirus DNA Load in Predicting the Long-term Risk of Cervical Cancer: A 15-Year Prospective Cohort Study in China.
    J Infect Dis. 2019;219:215-222.
    PubMed     Text format     Abstract available


    J Minim Invasive Gynecol

  34. ZHAO D, Li B, Wang Y, Liu S, et al
    Clinical Outcomes in Early Cervical Cancer Patients Treated with Nerve Plane-Sparing Laparoscopic Radical Hysterectomy.
    J Minim Invasive Gynecol. 2019 May 7. pii: S1553-4650(19)30213.
    PubMed     Text format     Abstract available


    J Vasc Interv Radiol

  35. AHMED O, Nguyen VD, Ginsburg M, Barry P, et al
    CT-Guided Placement of a Polyethylene Glycol Hydrogel in Brachytherapy for Gynecologic Malignancy to Limit Nontarget Organ Toxicity.
    J Vasc Interv Radiol. 2019;30:469-471.
    PubMed     Text format    


    LGBT Health

  36. PORSCH LM, Zhang H, Dayananda I, Dean G, et al
    Comparing Receipt of Cervical Cancer Screening and Completion of Human Papillomavirus Vaccination Using a New Construct of Sexual Orientation: A Serial Cross-Sectional Study.
    LGBT Health. 2019 May 8. doi: 10.1089/lgbt.2018.0196.
    PubMed     Text format     Abstract available


    Med Sci Monit

  37. YIN F, He H, Zhang B, Zheng J, et al
    Effect of Deubiquitinase Ovarian Tumor Domain-Containing Protein 5 (OTUD5) on Radiosensitivity of Cervical Cancer by Regulating the Ubiquitination of Akt and its Mechanism.
    Med Sci Monit. 2019;25:3469-3475.
    PubMed     Text format     Abstract available


    Mol Immunol

  38. BOLHASSANI A, Shahbazi S, Agi E, Haghighipour N, et al
    Modified DCs and MSCs with HPV E7 antigen and small Hsps: Which one is the most potent strategy for eradication of tumors?
    Mol Immunol. 2019;108:102-110.
    PubMed     Text format     Abstract available


    Oncoimmunology

  39. SEBAN RD, Robert C, Dercle L, Yeh R, et al
    Increased bone marrow SUVmax on 18F-FDG PET is associated with higher pelvic treatment failure in patients with cervical cancer treated by chemoradiotherapy and brachytherapy.
    Oncoimmunology. 2019;8:e1574197.
    PubMed     Text format     Abstract available


    PeerJ

  40. WU W, Sui J, Liu T, Yang S, et al
    Integrated analysis of two-lncRNA signature as a potential prognostic biomarker in cervical cancer: a study based on public database.
    PeerJ. 2019;7:e6761.
    PubMed     Text format     Abstract available


    PLoS One

  41. GETACHEW S, Getachew E, Gizaw M, Ayele W, et al
    Cervical cancer screening knowledge and barriers among women in Addis Ababa, Ethiopia.
    PLoS One. 2019;14:e0216522.
    PubMed     Text format     Abstract available

  42. PARK S, Lee S, Kim J, Kim G, et al
    Correction: DeltaNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.
    PLoS One. 2019;14:e0216968.
    PubMed     Text format     Abstract available

  43. LINDSTROM AK, Hermansson RS, Gustavsson I, Hedlund Lindberg J, et al
    Cervical dysplasia in elderly women performing repeated self-sampling for HPV testing.
    PLoS One. 2018;13:e0207714.
    PubMed     Text format     Abstract available


    Rev Assoc Med Bras (1992)

  44. BRITO AET, Matushita C, Esteves F, Gomes G, et al
    Cervical cancer - staging and restaging with 18F-FDG PET/CT.
    Rev Assoc Med Bras (1992). 2019;65:568-575.
    PubMed     Text format     Abstract available


    Saudi Med J

  45. AL-MADANI W, Ahmed AE, Arabi H, Al Khodairy S, et al
    Modelling risk assessment for cervical cancer in symptomatic Saudi women.
    Saudi Med J. 2019;40:447-451.
    PubMed     Text format     Abstract available


    South Asian J Cancer

  46. MISHRA GA, Pimple SA, Gupta SD
    Evaluation of cytology as secondary triage in visual inspection after application of 4% acetic acid-based cervical cancer screening program.
    South Asian J Cancer. 2019;8:102-107.
    PubMed     Text format     Abstract available


    Taiwan J Obstet Gynecol

  47. LEE CL, Huang KG
    Clinical trial should be more rigorous.
    Taiwan J Obstet Gynecol. 2019;58:306-307.
    PubMed     Text format    


    Wiad Lek

  48. KOTOWSKI A, Kotowska M, Warzyszynska A, Szymusik I, et al
    Cervical cancer - causes and prevention of hpv infections in the opinions of young polish women: a cross-sectional survey.
    Wiad Lek. 2019;72:327-335.
    PubMed     Text format     Abstract available


    Zhongguo Yi Xue Ke Xue Yuan Xue Bao

  49. GUO Y, Ma D, Jia FS, Liu J, et al
    [Proliferation of MicroRNA-365 and E74-like Factor 4 in Cervical Cancer Cells and Its Clinical Significance].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019;41:220-227.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: